Our mission is to prevent, treat and cure diabetes. Our vision is a world free of diabetes and its complications.
Joslin Diabetes Center undertakes diabetes research, clinical care, education and health and wellness programs on a global scale. We are dedicated to ensuring that people with diabetes live long, healthy lives, and we offer real progress in preventing and curing diabetes.
Joslin is an independent, nonprofit institution, academically affiliated with Harvard Medical School, and is recognized worldwide for driving innovative solutions in diabetes prevention, research, education, and care.
Joslin News & More
- Deciphering the New Cholesterol Treatment Guidelines for People with Diabetes
- Susan Bonner-Weir, Ph.D, Receives William Silen Lifetime Achievement in Mentoring Award
- Dr. Gail Musen’s Research into Cognitive Function in People with Type 2 Diabetes Receives Alzheimer’s Association Grant
- Joslin Diabetes Center and DGFEZ Sign MOU to Explore Opportunities to Collaborate
- Jennifer Sun, M.D., M.P.H., to Be Honored at 11th Annual Taste of Ginger
Today on the Joslin Blog
Multicultural Programs
Latino Diabetes Initiative | En Español
Asian American Diabetes Initiative
Upcoming Events
- Angela & Roi Shopping Event
April 20th - May 10th - Mark's Run
Sunday, May 3rd - Evening at POPS
Friday, May 8th - Field of Dreams WiffleBall Tournament
Saturday, May 9th
View all Events >>
Published online by Joslin for the diabetes community worldwide, Speaking of Diabetes, features Joslin news, insights on diabetes, the latest on diabetes research and stories about people of all ages who live with Type 1 and Type 2 diabetes — information sourced from a single team of experts: the doctors, educators and researchers at the Joslin Diabetes Center.
Joslin Research Updates
Joslin Discovery May Hold Clues to Treatments that Slow Aging and Prevent Age-Related Chronic Disease
In a study published today by Nature, researchers at Joslin Diabetes Center used a microscopic worm (C. elegans) to identify a new path that could lead to drugs to slow aging and the chronic diseases that often accompany it—and might even lead to better cosmetics. Read the full story.
